AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements
Elixir, a wholly owned subsidiary of Rite Aid, recently announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, recently announced it was selected as a limited distribution partner for VYVGART
Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs
Soleo Health has developed limited distribution networks by leveraging SoleMetrics ability to collect and deliver real-world, insightful data regarding a drug’s clinical capabilities, derived from its patients
Maxor Specialty Pharmacy has a focus on pulmonary disease
Limited Distribution Networks growth continues as Specialty Pharmacies compete to be chosen to distribute specialty pharmaceuticals. AMI’s report, Distribution Decision-Making for Specialty Drugs, found that Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market. Pharmaceutical manufacturers consider approximately 100-150 different specialty pharmacies (SPs) […]
How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]